HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carl G Figdor Selected Research

Intercellular Adhesion Molecule-3

10/2021Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
2/2003Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells.
3/2002Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carl G Figdor Research Topics

Disease

111Neoplasms (Cancer)
02/2022 - 09/2002
37Melanoma (Melanoma, Malignant)
01/2022 - 01/2003
9Hypersensitivity (Allergy)
11/2019 - 11/2003
7Infections
01/2018 - 03/2002
6Inflammation (Inflammations)
01/2018 - 07/2003
5Neoplasm Metastasis (Metastasis)
01/2015 - 12/2010
5Communicable Diseases (Infectious Diseases)
01/2012 - 02/2010
3Rheumatoid Arthritis
01/2021 - 02/2003
3Virus Diseases (Viral Diseases)
01/2013 - 07/2006
2Disease Progression
10/2021 - 09/2010
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2021 - 02/2016
2Lymphoma (Lymphomas)
10/2021 - 02/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 11/2019
2Colorectal Neoplasms (Colorectal Cancer)
10/2016 - 12/2010
2Ascites
10/2013 - 08/2011
2Porcine Reproductive and Respiratory Syndrome (PRRS)
03/2010 - 04/2008
2Graft vs Host Disease (Graft-Versus-Host Disease)
02/2010 - 09/2008
2Wounds and Injuries (Trauma)
07/2003 - 02/2003
1Testicular Neoplasms (Testicular Cancer)
01/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021
1Staphylococcal Infections
10/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021
1Rupture
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Multiple Sclerosis
01/2021

Drug/Important Bio-Agent (IBA)

46AntigensIBA
01/2022 - 01/2003
22VaccinesIBA
03/2020 - 09/2002
16Monophenol Monooxygenase (Tyrosinase)IBA
03/2020 - 11/2003
16Peptides (Polypeptides)IBA
07/2016 - 02/2003
15Neoplasm Antigens (Tumor Antigens)IBA
01/2019 - 09/2002
11CytokinesIBA
07/2016 - 12/2007
9Messenger RNA (mRNA)IBA
03/2020 - 04/2009
9Proteins (Proteins, Gene)FDA Link
09/2017 - 09/2003
9keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
03/2016 - 11/2003
7LigandsIBA
01/2019 - 02/2003
5Immune Checkpoint InhibitorsIBA
02/2022 - 12/2013
4Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2010
4DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
10/2021 - 03/2002
4Cancer VaccinesIBA
01/2021 - 01/2007
4NanovaccinesIBA
01/2021 - 06/2013
4Cisplatin (Platino)FDA LinkGeneric
03/2020 - 08/2011
4Interleukin-6 (Interleukin 6)IBA
02/2016 - 03/2009
4C-Type Lectins (C-Type Lectin)IBA
03/2010 - 02/2003
3AntibodiesIBA
02/2022 - 03/2012
3HLA-A Antigens (HLA-A)IBA
01/2022 - 01/2013
3IntegrinsIBA
10/2021 - 07/2011
3Intercellular Adhesion Molecule-3IBA
10/2021 - 03/2002
3Pharmaceutical PreparationsIBA
01/2021 - 09/2010
3Interferon Type IIBA
01/2018 - 11/2012
3RNA (Ribonucleic Acid)IBA
03/2017 - 07/2009
3PlatinumIBA
01/2017 - 08/2011
3Platinum Compounds (Compounds, Platinum)IBA
01/2017 - 08/2011
3TetraspaninsIBA
02/2016 - 02/2010
3Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
05/2014 - 11/2007
3Monoclonal AntibodiesIBA
10/2010 - 06/2004
3Pattern Recognition ReceptorsIBA
03/2010 - 04/2008
2IpilimumabIBA
01/2022 - 08/2016
2EpitopesIBA
01/2022 - 08/2002
2Protamines (Protamine Sulfate)FDA Link
11/2019 - 03/2017
2ChemokinesIBA
11/2017 - 01/2016
2Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2016 - 07/2012
2Matrix Metalloproteinases (MMPs)IBA
06/2013 - 02/2003
2Interleukin-10 (Interleukin 10)IBA
08/2011 - 05/2010
2Interleukin-4 (Interleukin 4)IBA
08/2011 - 04/2011
2Interleukin-2 (IL2)IBA
08/2011 - 01/2009
2Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
07/2011 - 03/2011
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2010 - 03/2010
2ferric oxide (iron oxide)IBA
04/2009 - 11/2005
2Differentiation AntigensIBA
01/2009 - 01/2004
2HLA Antigens (Human Leukocyte Antigens)IBA
05/2006 - 08/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2003 - 02/2003
2Heme (Haem)IBA
09/2003 - 07/2003
1Pentetic Acid (DTPA)FDA LinkGeneric
02/2022
1Immunoglobulin Fab FragmentsIBA
02/2022
1Polysaccharides (Glycans)IBA
10/2021
1Immunoglobulin Variable RegionIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
10/2021
1Mechanistic Target of Rapamycin Complex 1IBA
10/2021
1LectinsIBA
10/2021
1Complementarity Determining Regions (Complementarity Determining Region)IBA
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1PolymersIBA
01/2021
1Trans-Activators (Trans-Acting Factor)IBA
01/2021
1PerforinIBA
01/2021
1Connexin 43 (Connexin43)IBA
10/2020
1Adenosine (Adenocard)FDA LinkGeneric
10/2020
1NucleosidesIBA
10/2020
1NucleotidesIBA
10/2020
1ConnexinsIBA
10/2020

Therapy/Procedure

57Immunotherapy
01/2022 - 02/2003
18Therapeutics
01/2021 - 02/2003
4Intravenous Injections
10/2021 - 01/2015
4Lymph Node Excision (Lymph Node Dissection)
07/2016 - 09/2011
4Cryosurgery
08/2011 - 07/2006
3Treatment Delay
11/2019 - 12/2010
2Castration
01/2020 - 11/2019
2Immunomodulation
02/2015 - 09/2014
2Drug Therapy (Chemotherapy)
01/2014 - 06/2010
2Lasers (Laser)
10/2013 - 01/2004